EcoDrugPlus

Presenilin-2-Like

Ensembl ID : ENSSTUG00000024383
Gene Symbol: LOC115208527
3 Cross references
200 Possible Orthologues:

Presenilin-2-Like

Ensembl ID : ENSSTUG00000049336
Gene Symbol: LOC115178279
3 Cross references
199 Possible Orthologues:

Primary Amine Oxidase, Liver Isozyme-Like

Ensembl ID : ENSSTUG00000020837
Gene Symbol: LOC115199550
3 Cross references
409 Possible Orthologues:

Primary Amine Oxidase, Liver Isozyme-Like

Ensembl ID : ENSSTUG00000024810
Gene Symbol: LOC115171260
3 Cross references
409 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSSTUG00000042939
Gene Symbol: LOC115176317
3 Cross references
248 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSSTUG00000049345
Gene Symbol: LOC115162437
3 Cross references
249 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSSTUG00000015869
Gene Symbol: LOC115174133
3 Cross references
248 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSSTUG00000022283
Gene Symbol: LOC115172722
3 Cross references
249 Possible Orthologues:

Progesterone Receptor-Like

Ensembl ID : ENSSTUG00000005826
Gene Symbol: LOC115163863
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSTUG00000001746
Gene Symbol: PTGDR2
3 Cross references
130 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSTUG00000001567
Gene Symbol: PTGDR2
3 Cross references
138 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSTUG00000001549
Gene Symbol: PTGDR2
3 Cross references
141 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).